Pfizer/BioNTech to start vaccine studies in children
Pfizer/BioNTech has announced plans to start COVID-19 vaccine studies in children between the age of five and eleven in a few months time.
Advertisement
The companies’ current trial for children between 12 and 15 years started enrolling participants in October 2020 but it is now fully enrolled.
Pfizer/BioNTech said the relevant data will be submitted to the regulatory authorities in the second quarter of 2021, adding that they also have plans to study the vaccine in children younger than five later this year.
Advertisement
Africa ready to roll out COVID-19 vaccines
The World Health Organisation (WHO) says Africa is getting ready to roll out COVID-19 vaccines.
Advertisement
In a statement issued from in its headquarters in Brazzaville, Congo, on Thursday, WHO said the continent was planning a rapid vaccine rollout.
The statement said Matshidiso Moeti, WHO regional director for Africa, had briefed health ministers on the region’s overall state of readiness for Africa’s largest-ever immunisation drive.